Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · IEX Real-Time Price · USD
+0.040 (1.47%)
May 17, 2024, 4:30 PM EDT - Market closed

Lisata Therapeutics Statistics

Total Valuation

LSTA has a market cap or net worth of $22.93 million. The enterprise value is -$20.42 million.

Market Cap 22.93M
Enterprise Value -20.42M

Important Dates

The last earnings date was Thursday, May 9, 2024, after market close.

Earnings Date May 9, 2024
Ex-Dividend Date n/a

Share Statistics

LSTA has 8.31 million shares outstanding. The number of shares has increased by 3.84% in one year.

Shares Outstanding 8.31M
Shares Change (YoY) +3.84%
Shares Change (QoQ) +1.87%
Owned by Insiders (%) 18.78%
Owned by Institutions (%) 8.83%
Float 6.75M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.53
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 8.92, with zero debt.

Current Ratio 8.92
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -39.70% and return on invested capital (ROIC) is -59.23%.

Return on Equity (ROE) -39.70%
Return on Assets (ROA) -35.90%
Return on Capital (ROIC) -59.23%
Revenue Per Employee n/a
Profits Per Employee -$802,160
Employee Count 25
Asset Turnover n/a
Inventory Turnover n/a


Income Tax -3.13M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -29.91% in the last 52 weeks. The beta is 1.08, so LSTA's price volatility has been similar to the market average.

Beta (1Y) 1.08
52-Week Price Change -29.91%
50-Day Moving Average 2.95
200-Day Moving Average 2.64
Relative Strength Index (RSI) 46.36
Average Volume (30 Days) 12,593

Short Selling Information

The latest short interest is 14,812, so 0.18% of the outstanding shares have been sold short.

Short Interest 14,812
Short Previous Month 16,088
Short % of Shares Out 0.18%
Short % of Float 0.22%
Short Ratio (days to cover) 0.77

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -25.47M
Pretax Income -23.18M
Net Income -20.05M
EBITDA -23.00M
EBIT -23.18M
Earnings Per Share (EPS) -$2.46
Full Income Statement

Balance Sheet

The company has $43.35 million in cash and no debt, giving a net cash position of $43.35 million or $5.22 per share.

Cash & Cash Equivalents 43.35M
Total Debt n/a
Net Cash 43.35M
Net Cash Per Share $5.22
Equity / Book Value 43.00M
Book Value Per Share 5.18
Working Capital 42.23M
Full Balance Sheet

Cash Flow

Operating Cash Flow -18.86M
Capital Expenditures n/a
Free Cash Flow -18.86M
FCF Per Share -$2.27
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

LSTA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.84%
Shareholder Yield -3.84%
Earnings Yield -87.46%
FCF Yield -82.27%

Analyst Forecast

The average price target for LSTA is $15.00, which is 441.52% higher than the current price. The consensus rating is "Strong Buy".

Price Target $15.00
Price Target Difference 441.52%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -7.97%
Stock Forecasts

Stock Splits

The last stock split was on September 15, 2022. It was a reverse split with a ratio of 1:15.

Last Split Date Sep 15, 2022
Split Type Reverse
Split Ratio 1:15


Altman Z-Score n/a
Piotroski F-Score 1